BiotechCROPharmaceuticalPre-ClinicalRegulatory SubmissionRegulatory SubmissionsSENDSEND Advantage ServicesSensible SENDSubmit
Latest updates on SEND v4.0
Marc Ellison
With the new Implementation Guide due to go on public review this coming August, we take a closer look at the scope of SEND 4.0.

